Related Experiment Video
Updated: Jan 11, 2026

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Risk profiles and long-term mortality in premature and nonpremature peripheral artery disease from two prospective
Xiaoqi Ye1, Yan Li1, Siyu Chen2
1Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Insights
Premature peripheral artery disease (PAD) has unique risk factors and higher long-term mortality, especially from cardiovascular causes, compared to nonpremature PAD. Further research is needed to understand these differences.
Area of Science:
- Cardiovascular Medicine
- Epidemiology
- Vascular Surgery
Background:
- Peripheral artery disease (PAD), especially premature PAD, is understudied.
- Distinct risk profiles and survival outcomes for premature PAD are not well understood.
- This study compares risk factors and long-term mortality between premature and nonpremature PAD.
Purpose of the Study:
- To compare risk factors and long-term mortality between premature and nonpremature PAD.
- To identify distinct characteristics of premature PAD.
- To assess survival outcomes associated with different PAD subtypes.
Main Methods:
- Analysis of two large cohorts: UK Biobank (N=348,766) and NHANES (N=6539).
- Premature PAD defined by sex-specific age cutoffs (men <55, women <65 years).
- Multinomial logistic regression and Cox proportional hazards models used to assess risk factors and mortality.
Main Results:
- Premature PAD patients were predominantly female with fewer cardiometabolic comorbidities.
- Peripheral neuropathy was a significant risk factor for premature PAD but not nonpremature PAD.
- Adjusted analyses revealed higher all-cause and cardiovascular mortality risks for premature PAD compared to nonpremature PAD.
Conclusions:
- Premature PAD presents distinct risk profiles.
- Premature PAD is associated with significantly higher adjusted long-term mortality, particularly from cardiovascular causes.
- Further research is required to elucidate the mechanisms behind these observed differences.
Background:
Peripheral artery disease (PAD), particularly premature PAD, remains understudied. It is still unclear whether premature PAD exhibits distinct risk profiles and survival outcomes compared with nonpremature PAD. We aimed to compare risk factors and long-term mortality between premature and nonpremature PAD using two large cohorts.
Methods:
In this study, we analyzed data from the UK Biobank (N = 348,766) and the U.S. National Health and Nutrition Examination Survey (NHANES; N = 6539). Premature PAD was defined using a sex-specific age cutoff (men <55 years, women <65 years), with sensitivity analyses using a 50-year cutoff. Participants were classified into three groups: no PAD, premature PAD, and nonpremature PAD groups. Multinomial logistic regression assessed associations between risk factors and PAD subtypes. Cox proportional hazards models estimated associations of PAD subtypes with all-cause and cardiovascular mortality risks.
Results:
Patients with premature PAD were predominantly female with fewer cardiometabolic comorbidities. Peripheral neuropathy was a strong risk factor specifically for premature PAD (UK Biobank: odds ratio [OR] = 3.96, 95% confidence interval [CI]: 2.73-5.73; NHANES: OR = 2.01, 95% CI: 1.28-3.17), whereas nonpremature PAD showed no significant association (UK Biobank: OR = 1.32, 95% CI: 0.66-2.65; NHANES: OR = 0.87, 95% CI: 0.65-1.16). Over a mean follow-up period of 13.2 (UK Biobank) and 14.9 (NHANES) years, unadjusted analyses showed the highest mortality in nonpremature PAD among the three groups. However, after full adjustment for potential confounders, the patterns of mortality shifted. Premature PAD had a higher all-cause mortality risk (UK Biobank: hazard ratio [HR] = 2.15, 95% CI: 1.93-2.39; NHANES: HR = 2.15, 95% CI: 1.41-3.29) than nonpremature PAD (UK Biobank: HR = 1.91, 95% CI: 1.75-2.09; NHANES: HR = 1.52, 95% CI: 1.28-1.80). Premature PAD also had a higher cardiovascular mortality risk (UK Biobank: HR = 3.10, 95% CI: 2.33-4.13; NHANES: HR = 4.33, 95% CI: 2.47-7.57) vs nonpremature PAD (UK Biobank: HR = 2.26, 95% CI: 1.76-2.88; NHANES: HR = 1.66, 95% CI: 1.34-2.07). This was further confirmed in a direct comparison among patients with PAD, which showed that premature PAD carried a significantly higher risk of cardiovascular mortality than nonpremature PAD.
Conclusions:
Premature PAD exhibited distinct risk profiles and had higher adjusted long-term mortality than nonpremature PAD, particularly from cardiovascular causes. Future studies are needed to investigate the mechanisms underlying these differences.
More Related Videos
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Peripheral Artery Disease IV: Nursing Management
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management

